F2-isoprostane and prostaglandin F2α metabolite excretion rate and day to day variation in healthy humans

被引:39
作者
Helmersson, J [1 ]
Basu, S [1 ]
机构
[1] Uppsala Univ, Fac Med, Clin Nutr Res Unit, SE-71525 Uppsala, Sweden
来源
PROSTAGLANDINS LEUKOTRIENES AND ESSENTIAL FATTY ACIDS | 2001年 / 65卷 / 02期
关键词
D O I
10.1054/plef.2001.0295
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Isoprostanes are mainly formed in vivo by a non-enzymatic free radical catalysed oxidation of arachidonic acid. Studies have indicated that a major isoprostane, 8-iso-PGF(2 alpha) in plasma and urine is a reliable biomarker of oxidative stress. Prostaglandins are formed by enzymatic oxidation of arachidonic acid catalysed by cyclooxygenase (COX). 15-Keto-dihydro-PGF(2 alpha), a major metabolite of prostaglandin F-2 alpha, in plasma, and also found in urine, is considered to be a useful biomarker of inflammation. To investigate the excretion pattern and day to day variation of 8-iso-PGF(2 alpha), and 15-keto-dihydro-PGF(2 alpha) in healthy individuals, morning urine samples were collected from 13 volunteers on 10 successive days. The samples were analysed for free 8-iso-PGF(2 alpha) and 15-keto-dihydro-PGF(2 alpha) by radioimmunoassay. The mean excretion rate of 8-iso-PGF(2 alpha) was 0.27 +/-0.11 nmol/mmol creatinine (mean +/- SD, n=13) and the coefficient of variation was 42% during the 10 days. The mean excretion rate of 15-keto-dihydro-PGF(2 alpha) was 0.46 +/-0.19 nmol/mmol creatinine, giving a coefficient of variation of 41%. The mean values of 8-iso-PGF(2 alpha) were significantly correlated with the mean values of 15-keto-dihydro-PGF(2 alpha) (r=0.68, P=0.01). In conclusion, day to day biological variation in urinary excretion rate of 8-iso-PGF(2 alpha) and 15-keto-dihydro-PGF(2 alpha) should be taken into account in evaluating a clinical study unless a large increase or decrease of these parameters has been obtained. (C) 2001 Harcourt Publishers Ltd.
引用
收藏
页码:99 / 102
页数:4
相关论文
共 27 条
[1]  
AWAD JA, 1995, HEPATOLOGY, V22, P962, DOI 10.1016/0270-9139(95)90321-6
[2]   Measurement of urinary 8-epi-prostaglandin F-2 alpha, a novel index of lipid peroxidation in vivo, by immunoaffinity extraction gas chromatography mass spectrometry. Basal levels in smokers and nonsmokers [J].
Bachi, A ;
Zuccato, E ;
Baraldi, M ;
Fanelli, R ;
Chiabrando, C .
FREE RADICAL BIOLOGY AND MEDICINE, 1996, 20 (04) :619-624
[3]  
BASU S, 1987, ACTA VET SCAND, V28, P409
[4]   Metabolism of 8-iso-prostaglandin F2α [J].
Basu, S .
FEBS LETTERS, 1998, 428 (1-2) :32-36
[5]   Oxidative injury and survival during endotoxemia [J].
Basu, S ;
Eriksson, M .
FEBS LETTERS, 1998, 438 (03) :159-160
[6]   Radioimmunoassay of 8-iso-prostaglandin F2α:: an index for oxidative injury via free radical catalysed lipid peroxidation [J].
Basu, S .
PROSTAGLANDINS LEUKOTRIENES AND ESSENTIAL FATTY ACIDS, 1998, 58 (04) :319-325
[7]   Oxidative injury induced cyclooxygenase activation in experimental hepatotoxicity [J].
Basu, S .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1999, 254 (03) :764-767
[8]   Radioimmunoassay of 15-keto-13,14-dihydro-prostaglandin F2α:: an index for inflammation via cyclooxygenase catalysed lipid peroxidation [J].
Basu, S .
PROSTAGLANDINS LEUKOTRIENES AND ESSENTIAL FATTY ACIDS, 1998, 58 (05) :347-352
[9]   Raised levels of F2-isoprostanes and prostaglandin F2α in different rheumatic diseases [J].
Basu, S ;
Whiteman, M ;
Mattey, DL ;
Halliwell, B .
ANNALS OF THE RHEUMATIC DISEASES, 2001, 60 (06) :627-631
[10]   Development of a novel biomarker of free radical damage in reperfusion injury after cardiac arrest [J].
Basu, S ;
Nozari, A ;
Liu, XL ;
Rubertsson, S ;
Wiklund, L .
FEBS LETTERS, 2000, 470 (01) :1-6